Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Ibrutinib for chronic graft-versus-host disease after failure of prior therapy have?
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy has 505 citations in the OpenAlex counts ScholarIQ stores.
When was Ibrutinib for chronic graft-versus-host disease after failure of prior therapy published?
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy has 2017 year in the ScholarIQ index.
What is the open-access status of Ibrutinib for chronic graft-versus-host disease after failure of prior therapy?
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy has bronze oa status in the ScholarIQ index.
What is the DOI of Ibrutinib for chronic graft-versus-host disease after failure of prior therapy?
The DOI for Ibrutinib for chronic graft-versus-host disease after failure of prior therapy is on the source record.
What is the PMID of Ibrutinib for chronic graft-versus-host disease after failure of prior therapy?
The PMID for Ibrutinib for chronic graft-versus-host disease after failure of prior therapy is on the source record.
What is the OpenAlex record for Ibrutinib for chronic graft-versus-host disease after failure of prior therapy?
The OpenAlex for Ibrutinib for chronic graft-versus-host disease after failure of prior therapy is on the source record.